Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Mammary Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07469709
What this trial is testing

Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks

Who this might be right for
Breast CancerColo-rectal CancerOvarian Cancer+2 more
Fondazione del Piemonte per l'Oncologia 850
Not applicableStudy completedNCT00005957
What this trial is testing

Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 1,832
Early research (Phase 1)Ended earlyNCT01816555
What this trial is testing

Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma

Who this might be right for
Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Medical University of South Carolina 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04243616
What this trial is testing

Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer

Who this might be right for
Invasive Breast Cancer
Medical College of Wisconsin 36
Not applicableActive Not RecruitingNCT02802553
What this trial is testing

Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions

Who this might be right for
Invasive Breast Cancer
Case Comprehensive Cancer Center 2
Early research (Phase 1)Study completedNCT01344031
What this trial is testing

MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor PositiveInvasive Breast CarcinomaRecurrent Breast Carcinoma+1 more
National Cancer Institute (NCI) 31
Post-approval studies (Phase 4)Study completedNCT00127933
What this trial is testing

XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 157
Not applicableUnknownNCT05754502
What this trial is testing

Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy

Who this might be right for
Breast Cancer
Consorzio Oncotech 300
Testing effectiveness (Phase 2)Study completedNCT02689427
What this trial is testing

Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 24
Not applicableActive Not RecruitingNCT04918082
What this trial is testing

Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique

Who this might be right for
Breast NeoplasmsQuality of LifeSurvivorship
University Hospital Center of Martinique 133
Not applicableUnknownNCT03630913
What this trial is testing

Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma

Who this might be right for
Invasive Breast CancerAxillary Metastases
Institut Cancerologie de l'Ouest 385
Testing effectiveness (Phase 2)Study completedNCT02199418
What this trial is testing

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 132
Testing effectiveness (Phase 2)Study completedNCT02530489
What this trial is testing

Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaInvasive Breast CarcinomaTriple-Negative Breast Carcinoma
M.D. Anderson Cancer Center 37
Early research (Phase 1)Study completedNCT04481113
What this trial is testing

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more
OHSU Knight Cancer Institute 8
Not applicableLooking for participantsNCT05196087
What this trial is testing

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Who this might be right for
Breast CancerMelanomaGastrointestinal Neuroendocrine Tumor
University Health Network, Toronto 500
Not applicableLooking for participantsNCT07280143
What this trial is testing

The Development of MASLD Among Survivors of Breast or Colorectal Cancer

Who this might be right for
Breast Cancer SurvivorsColorectal (Colon or Rectal) Cancer SurvivorsMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
University of Bern 200
Not applicableStudy completedNCT02575612
What this trial is testing

Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
Heidelberg University 50
Not applicableStudy completedNCT04107636
What this trial is testing

Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance

Who this might be right for
Breast Cancer
Radboud University Medical Center 45
Large-scale testing (Phase 3)Active Not RecruitingNCT05629585
What this trial is testing

Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

Who this might be right for
Breast Cancer
AstraZeneca 1,174
Not applicableEnded earlyNCT01609920
What this trial is testing

Nodal Staging in Breast Cancer With MRL

Who this might be right for
Breast Neoplasms
Maastricht University Medical Center 97
Next Page